Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

IPO Review - Heranba Industries Ltd

Posted On: 2021-02-22 06:36:22 (Time Zone: Arizona, USA)


Heranba Industries (Heranba) incorporated in 1992, is an agrochemical company. It is also one of the leading domestic producers of synthetic pyrethroids. The company is present in the entire product value chain of the agrochemicals industry. The business verticals include (a) domestic bulk sales of Technicals (31.6% of FY20 sales), (b) technicals bulk exports (36.5%) (c) branded formulations (12.7%), (d) formulations exports (12.8%) and (e) insect control chemicals (6.4%). Heranba has more than 9,400 dealers having access to multiple states in India. It has three manufacturing facilities in and around Vapi with a capacity of 14,024 MTPA.

Investment Rationale

Leading integrated domestic player in synthetic pyrethroids

Heranba is one of the leading domestic producers of pyrethroids (~68% of FY20 revenues; 19.5% domestic market share in 2019). It is in the entire value chain of synthetic pyrethroids that provides flexibility to shift between products depending on the demand-supply and pricing dynamics. The company also has a strong pending product pipeline in pyrethroids including formulations filed by partners in domestic, export markets. Apart from this, more than half of the global demand for Pyrethroids comes from China. Hence, due to shutdown of chemical plants in China amid pollution, higher volumes of Pyrethroids are expected to be exported out of India.

Strong product portfolio, wide distribution network

Heranba manufactures and supplies Technicals to leading agrochemical companies operating in and outside India. In domestic formulations, it has more than 9,400 dealers having access to 21 depots in multiple states. The company's International distribution partners have obtained registrations for 371 products in 41 countries across the Middle East, CIS, Asia, South East Asia and Africa. Further, 172 of the company's products have been filed by its overseas customers, which are pending for registration.

Priced at FY20 P/E of 25.7x on upper band

Benefiting from being an integrated pyrethroids manufacturer with a strong product pipeline, geographical expansion coupled with favourable macro factors are likely to drive growth. Apart from this, it has one of the strongest return ratios in Industry and healthy balance sheet. We have a SUBSCRIBE recommendation on the IPO. At Rs. 627, the stock is available at 25.7x FY20.

For details, click on the link below: https://www.icicidirect.com/mailimages/IDirect_Heranba_IPOReview.pdf


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

ICICI Lombard General Insurance Company - Cyclical recovery can protract; fundamentals remain intact - ICICI Securities

HDFC Bank - Resilience and consistency displayed to its core - ICICI Securities

Home First Finance Company - Tech-led affordable housing play at affordable valuations - ICICI Securities

Q4FY21 Result Update - Wipro Ltd - ICICI Direct

ICICI Direct - Covid Recovery Pulse - E-Way bill generation ends March 2021 on strong note...

Derivatives Strategy - Positional Future - ICICI Direct

Gladiator Stocks - Escorts - ICICI Direct

Q4FY21 Company Update - Tata Metaliks - ICICI Direct

Q4FY21 Result Update - MindTree Ltd - ICICI Direct

Q4FY21 Result Update - HDFC Bank - ICICI Direct

ICICI Direct Derivatives Weekly View (April 16): Sustainability above 14700 may trigger fresh uptrend...

Market Outlook - Technical - By Dharmesh Shah, Head - Technical, ICICIdirect

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on Monsoon outlook

ADD on Wipro - Improving growth visibility - HDFC Securities

Building Materials 4QFY21 Results Preview - Strong demand to support robust margin - HDFC Securities

Consumer Discretionary 4QFY21 Results Preview - Bargains few and far between - HDFC Securities

Consumer Durables 4QFY21 Results Preview - HDFC Securities

Wipro - Q4FY21 Result Update - YES Securities

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 Monthly Trade Balance

Wipro - Q4FY21 Result Update - Lofty multiples leave limited margin of safety - ICICI Securities

FMCG & Alco Bev 4QFY21 Results Preview - HDFC Securities

Maintain BUY on Infosys - Q4FY21 Results Review - Buy the dip - HDFC Securities

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 WPI Data released today

Non-leveraged financials 4QFY21 Results Preview - HDFC Securities

Infosys - A reality check! - ICICI Securities

Infosys - Q4FY21 Result Update - YES Securities

Polymer price tracker - PVC prices continue to rise - April 15, 2021 - ICICI Securities

Bharti Airtel - Restructuring aimed at digital biz, AGR-tax efficiency - ICICI Securities

Astral Limited - On a strong footing; top pick in pipes - ICICI Securities

Q4FY21 Result Update - Infosys - ICICI Direct

Q4FY21 Result Update - Tata Consultancy Services - ICICI Direct

Company Update - Coforge Ltd - ICICI Direct

Tata Consultancy Services - Q4FY21 Result Update - ICICI Securities

Company Update - Ambuja Cement - ICICI Direct

Banks & NBFCs 4QFY21 Results Preview - HDFC Securities

ADD on Tata Consultancy Services - Strong progression - HDFC Securities

YES SECURITIES on Tata Consultancy Services Q4 FY21 results

Suman Chowdhury, Chief Analytical Officer - Acuité Ratings, on IIP data released on April 12, 2021

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research, on March 2021 CPI Data

Q4FY21 Result Preview - Retail - ICICI Direct

Q4FY21 Result Preview - Auto and auto ancillary - ICICI Direct

Monetary Policy Update - April 2021 - ICICI Direct

Q4FY21 Result Preview - Banking & Financial Services - ICICI Direct

It would have helped if the sector received benefit from MPC: Realtors

Views on RBI Policy - April 7, 2021 - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Mr. Rajiv Sabharwal, MD and CEO, Tata Capital on the RBI's Monetary Policy announcement today

Realtors expected more from RBI MPC

Comments on RBI MPC announcement from Muthoot Finance, Creditas Solutions, Kotak Mahindra Bank

MPC announcement - April 7, 2021 - Acuité Ratings & Research

Views on RBI Policy - April 7, 2021 - Mr. Dhiraj Relli, MD &CEO, HDFC Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020